Skip to content

Homoeopathic Management Of Premenstrual Dysphoric Disorder

A Single Group Pre-Post Intrventional Study To Assess The Effectiveness Of Individualised Homoeopathic Medicine In The Treatment Of Premenstrual Dysphoric Disorder Using Kents Repertory - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/12/077899
Enrollment
55
Registered
2024-12-10
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F328- Other depressive episodes

Interventions

Intervention1: Individualised Homoeopathic Medicine: Dose - 2 to 4 Potency - Both Centesimal(30C,200C,1M) and Fifty Millesimal potency will be used.All medicine procured will be GMP certified. Route o

Sponsors

Dr Suparja Sinha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Women of Reproductive age group between 15 years to 49 years. 2. An increase in severity or presence of symptoms of DSM- V at least one of the physical and one of the mental symptoms 1-10 days before onset of menses, for at least 2 preceding menstrual cycle. 3. The symptoms are associated with clinically significant distress or interference with work, school, usual social activities, or relationships with others 4.Relief of the above symptoms within 3 days of onset of menstrual cycle and not come back within at least 12 days of that cycle. 5.Patient who can give written consent or assent as needed.

Exclusion criteria

Exclusion criteria: 1. A professional athlete 2. Receive other treatment for PMS. 3. Patient with any malignancy. 4. Patient on OCP. 5. History of major psychriatic disorder over the past 2 years. 6. History of drug abuse, alcohol, hookah during the last 2 years.

Design outcomes

Primary

MeasureTime frame
Symptoms assessment by using Premenstrual symptom screening toolTimepoint: At base line, 4th week, 8th week, 12th week, 16th week, 20th week, 24th week.

Secondary

MeasureTime frame
Quality of life assessment using EQ-5D-5L scaleTimepoint: At base line, 4th week, 8th week, 12th week, 16th week, 20th week, 24th week

Countries

India

Contacts

Public ContactDr Suparja Sinha

Mahesh Bhattacharyya Homoeopathic Medical College and Hospital

dr.samit77@gmail.com9875371414

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026